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Background: Periprosthetic bone remodeling, which is a phenomenon observed in all femoral stems, has
a multifactorial origin as it depends on factors related to the patient, the surgical technique, and the
design of the implant. To determine the pattern of remodeling produced by 2 models of anatomic
cementless implants, we quantified the changes in bone mineral density (BMD) in the 7 areas of Gruen
observed at different moments after surgery during the first postoperative year.
Methods: A prospective, comparative, controlled, 1-year follow-up densitometric study was carried out
in 2 groups of patients suffering from primary unilateral hip osteoarthritis. In the first group, with 68
patients, an ABG-II stem was implanted. In the second, with 66 patients, the ANATO stem was used. The
contralateral, healthy hip was taken as a control.
Results: Both groups showed a decrease in BMD at 3 months in all the areas, which recovered at the end
of the study, except in zone 7: there was a 17.7% decrease in the ABG-II group and a 5.9% decrease in the
ANATO group. In zones 2 and 6, where more loads are transmitted, conservation of BMD is observed in
response to Wolff's law. The differences in the pattern of remodeling between groups were maintained
despite the age, gender, and BMI of the patients or the size of the implants.
Conclusion: The ANATO stem achieved a more efficient transmission of loads at the metaphyseal level,
which promotes bone preservation at the proximal femur, than the ABG-II stem.
© 2020 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Bone remodeling after a hip arthroplasty occurs with all models
of cementless femoral stems because of the change in the pattern of
load transmission produced after the surgery. The magnitude of
these adaptive changes is multifactorial, with factors attributable to
the patient, to the surgical technique, and to the implant [1-4].
On another note, it is accepted that a decrease of 30%-40% in the
bone mineral density (BMD) is necessary to appreciate changes in
the bone density in a simple radiograph [5]. For this reason, dual-
energy radiograph absorptiometry is considered the ideal method
to quantify the changes in BMD produced by different stems over
the years [6-8]. For the location of the changes, the Gruen zones
have been used as a reference. Zone 1 corresponds to the greater, House, 19, 50011 Zaragoza,
r Inc. on behalf of The American As
by-nc-nd/4.0/).trochanter, zone 7 to the lesser trochanter, and zone 4 is distal to
the tail of the implant. Zones 2 and 3 correspond to the external
portion of the middle and distal third of the femur around the
implant, respectively. Zones 6 and 5 correspond to the internal
portion of the middle and distal third, respectively.
In the last 2 decades, several clinical studies and results of na-
tional registries of the ABG-I stem (Stryker, Kalamazoo, MI) showed
good clinical and radiological evolution [9,10]. However, in densi-
tometric studies, this implant produced a 12% decrease in BMD in
zone 1 and 27% in zone 7 at the end of the first postoperative year.
The redesign of this implant (ABG-II; Stryker) in the late 1990s
maintained good clinical and radiological results, improving the
results of bone remodeling [11] but still showing a decrease in BMD
of 7% in zone 1 and 16% in zone 7 [12].
In 2015, the evolution of the ABG-II stem (ANATO, Stryker,
Kalamazoo, MI) was marketed. This new implant has 2 options of
the femoral neck, is made with a different titanium alloy, and also
has a biological coating of greater porosity, which is different from
the grit-blasted surface of the ABG-II stem. Finally, the length of thesociation of Hip and Knee Surgeons. This is an open access article under the CC BY-
Figure 1. (a) ABG-II stem. (b): ANATO stem.
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mm from that size onward. When this new stem was used in our
department, a pilot study was carried out with the first 37 patients
who received this implant. The results showed a reduced decrease
in bone mass at the proximal femur, particularly in area 7 [13],
compared with the ABG-II stem [11,12].
With the intention of confirming these findings and avoiding
the bias of studies carried out in different time periods, by different
surgeons and with modifications in the surgical technique and
postoperative care, a prospective comparative study including both
implants was designed and subsequently carried out in 2017. The
purpose of this study was to quantify the variation of the peri-
prosthetic BMD caused by these 2 implants throughout the first 12
postoperative months, taking the contralateral, healthy hip as a
control.
Material and methods
To quantify the periprosthetic bone remodeling caused by the
ABG-II and ANATO stems, a prospective, comparative, densito-
metric study was designed, taking the contralateral, healthy hip as
a control. The patients included in the study were operated be-
tween March and September 2017. The clinical data were obtained
from the clinical history and radiograph. The study was completed
with the functional assessment of the operated hip using the Merle
D’Aubigne Postel score and radiographs anteroposterior of the
pelvis and axial of the affected hip) at the same time that each
densitometric study was carried out. The study was approved by
the ethics committee.
Densitometric evaluation
The variation of the BMD was used as a criterion of evolution in
boxes of 30-by-30 pixels in each of the 7 areas of the Gruen zones in
both the healthy and the operated hips. BMD determinations were
performed using the LUNAR DPX enCORE densitometer (GE
Healthcare, Madison, WI) using metal exclusion software. The an-
alyses were made with a careful superimposition of the stem in all
the scans of each patient to analyze the same regions of interest.
The scans in both hips were made preoperatively and 1 year after
the surgery. In the operated hip, 3 additional determinations were
made: in the immediate postoperative period and 3 and 6 months
after the surgery. The densitometric results were compared
grouping the patients based on the stem used and analyzing any
possible differences between the age, gender, weight, and size of
the implant.
To ensure the reliability of the scans [14] and reproduce the
position of the hip during the densitometric study, all the patients
were placed in the supine position on the scanner table, with the
knees and hips in extension and the whole limb in a neutral posi-
tion supported on a rigid plastic device that immobilized the leg
with Velcro tapes.
Study population
The patients included in the study suffered from unilateral hip
osteoarthritis, Dorr A femoral morphology, with no radiological
signs of osteoporosis. They had a healthy contralateral hip and
accepted to participate in the study.
The patients were included in 2 groups depending on the day of
inclusion on the surgical waiting list (even days: ABG-II [Stryker];
odd days: ANATO). It was proposed to include a minimum of 60
patients in each group, and finally 68 were included in the ABG-II
group and 66 in the ANATO group. All patients completed the 1-
year follow-up.The implant used in thefirst groupwas theABG-II stemand, in the
second group, the ANATO® stem (Stryker), with uncemented cup
(TRIDENT PSL®, Stryker, Kalamzazoo, MI) and ceramic-polyethylene
bearing couple (the latter 2 were not part of the study). The ABG-II
stem is an uncemented anatomical stem, of metaphyseal press fit,
made with an alloy of titanium-molybdenum-zinc-iron, with a 7-
degree femoral neck anteversion. At the metaphyseal level, it has a
scale-like design on the anterior and posterior sides of the implant,
with a grit-blasted surface and a hydroxyapatite coating of 70 mi-
crons. The ANATO stem is made of titanium-aluminum-vanadium
(Fig. 1a and b). It has 2 femoral neck options: neutral or with 7 de-
grees of anteversion. At the metaphyseal level, it also has a scale-like
designon the anterior andposterior sides of the implant,whichhelps
transform the axial forces into transverse ones, improving the sta-
bility of the implant. At this level, the surface is rough, created with a
300-micron titanium spray and a 50-micron PureFix® (Stryker,
Kalamazoo, MI) hydroxyapatite coating. From size 4, the total length
of bigger implants does not increase, always limited to 120mm. It has
the same offsets and neck lengths as the ABG-II® stem.Surgical technique
All the patients were operated on using a posterolateral
approach performed by the same group of 5 surgeons. Antibiotic
prophylaxis with cefazolin, or teicoplanin in case of allergy, was
used in the first 24 postoperative hours, and antithrombotic pro-
phylaxis with low-molecular-weight heparins was used for the
following 30 days.
The patients rested in bed for the first 24 hours, after which the
drainage of the wound was removed. From that moment, sitting on
the edge of the bed or in a high chair was started. Next, walking
with crutches or a walker was authorized, in partial weight-
bearing, according to tolerance. To minimize micromovement
that can affect bone growth on the surface of the implant, and the
risk of periprosthetic fractures, the patients continued using the
crutches for 6 weeks, and later, using just one crutch, progressive
full loading was authorized. After 3 months, complete weight-
bearing without any supportive help and free movement was
authorized.
Table 1
Demographics of the patients included in the study.
ABG-II (n ¼ 68) ANATO (n ¼ 66)
Men/women 47/21 56/10
BMI 28.1 kg/m2 32.8 kg/m2
Age 59 (SD: 10.8; min: 28, max:
76)
57 (SD: 8.4; min: 36, max: 75)
Diagnosis 100% osteoarthritis 100% osteoarthritis
Size of the
stem
2: 2 patients 3: 10 patients
3: 13 patients 4: 26 patients
4: 25 patients 5: 15 patients
5: 17 patients 6: 11 patients
6: 19 patients 7: 4 patients
7: 2 patients (100% with 7 degrees anteverted
neck)
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The statistical study was carried out using the SPSS program,
version 20.0. For the comparison of percentages, the chi square test
was used; for the means with homogeneous parameters, Student's
t-test was used; and for the means with nonhomogeneous pa-
rameters, the Kruskal-Wallis test was used.Results
The demographics of the patients are shown in Table 1. In both
groups, the male-female distribution was not homogeneous,
showing a clear male predominance. The reason for these differ-
ences is that the choice of the implant is made considering the boneTable 2
Changes in BMD in the ABG-II group.
Gruen zones Pre-Iqx Post-Iqx Reference



































Pre-Ipx, pre-operative; Post-Iqx, post-operative (reference value).
Bold values indicates the statistical significance.quality observed on the preoperative radiograph and the femoral
morphology. As a result, we use this implant in 52% of our patients,
most of whom were male. The rest of demographic variables (BMI,
age, diagnosis, and the size of implant used) did not show any
differences between groups.
The bone-mass evolution in both groups throughout the follow-
up is shown in Tables 2 and 3. As osteoarthritic hips are almost
always extrarotated and flexed, the preoperative values were not
considered and the postoperative values were taken as a reference
for monitoring BMD in the operated hip. Three months post-
operatively, a generalized bone loss was observed in all the areas,
being more marked in zone 7. This decrease in BMD was attributed
to the surgical aggression of the rasps to the cancellous bone and
endosteal blood supply and to a reduced physical activity in the
postoperative period.
At the 6-month determination of the ABG-II group, a partial
bone recovery was observed in zones 1-2-3-4-5-6, which was more
evidentdwith positive remodelingdin zones 2 and 6. On the
contrary, in zone 7, a moderate additional bone loss was observed,
already statistically significant (decrease of 15.3%). One year post-
operatively, this pattern of remodeling was stable, showing slight
losses in zone 1 and distal areas, bone preservation in zones 2 and 6,
and statistically significant proximal atrophy in zone 7 only
(decrease of 17.7%).
The evolution of BMD at 6 months in the ANATO group also
showed a recovery in all areas, with positive remodeling in zones 1, 2,
and 6. In zone 7, a significant bone loss of 6.3%was observed. One year
postoperatively, this pattern of remodeling was maintained, with
minimal losses in distal areas; bone preservation in zones 1, 2, and 6;





































Changes in the BMD in the ANATO group.
Gruen zones Pre-Iqx Post-Iqx Reference 3 mo 6 mo 1 y
Zone 1 967 936 916 959 957
Variation 2.2% þ2.4% þ2.2%
SD 200 164.9 178 202 212
Max-min 523-1617 611-1372 447-1427 419-1421 407-1424
P .239 .400 .673
Zone 2 1913 1856 1809 1871 1895
Variation 2.6% þ0.9% þ2.1%
SD 295 256 262 259 258
Max-min 1010-2315 1305-2396 1145-2459 1176-2335 1336-2713
P .228 .930 .318
Zone 3 2210 2194 2085 2172 2177
Variation 5% 1.1% 0.8%
SD 281 281 281 287 277
Max-min 1331-2467 1570-2839 1325-2659 1463-2872 1501-2790
P .061 .266 .249
Zone 4 2122 2105 2030 2058 2080
Variation 3.6% 2.7% 1.2%
SD 273 296 294 291 295
Max-min 1489-2750 1488-2835 1345-2659 1382-2607 1459-2791
P .131 .119 .165
Zone 5 2161 2140 2042 2095 2106
Variation 4.6% 2.1% 1.6%
SD 305 285 301 299 306
Max-min 1267-2692 1458-2647 1317-2593 1430-2619 1480-2739
P .101 .125 .168
Zone 6 1780 1683 1649 1719 1774
Variation 2.1% þ2.1% þ5.2%
SD 284 348 265 257 262
Max-min 1002-2248 1478-2374 879-2264 1201-2400 1234-2338
P .434 .216 .057
Zone 7 1432 1400 1263 1313 1318
Variation 9.8% 6.3% 5.9%
SD 201 212 218 258 248
Max-min 790-1717 1028-2045 491-1843 761-2002 670-1904
P .001 .002 .005
Pre-Ipx, pre-operative; Post-Iqx, post-operative (reference value).
Bold values indicates the statistical significance.
Figure 2. Radiographic changes around the ABG-II showing rounding of the calcar and light atrophy at the greater trochanter. Immediate postoperative image on the left; 1-year
postoperative image on the right.
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Figure 3. Radiographic changes around the ANATO stem showing a reduced calcar atrophy and bone apposition at the shoulder of the stem. Immediate postoperative image on the
left; 1-year postoperative image on the right.
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different times of the follow-up, no significant differences were
observed in zones 2 to 6. Only in zone 1 of the ANATO group was a
positive remodeling found from the 6th month, which did not exist
in the ABG-II group. This finding was maintained at the end of the
study, with a 2.2% increase in the ANATO group, compared with a
4.1% decrease in the ABG-II group, without achieving statistical sig-
nificance. However, the changes in BMD in zone 7 between these
implants weremore pronounced and statistically significant at 6 and
12 months. In the ABG-II group, a 15.3% decrease in BMD was
observed at 6 months, while in the ANATO group, the decrease was
limited to 6.3% (P .001). At 12 months, the ABG-II group showed a
decrease in BMD of 17.7%, in contrast to a decrease of 5.9% observed
in the ANATO group (P .002).
When the changes in BMD of these stems were analyzed ac-
cording to the gender, BMI, and age of the patients, we observed
the same differences between stems. When the BMD differences
between implants were studied according to the size used, size 4
was chosen as the cutoff point because from that size onward,
the ANATO stem does not increase its length, unlike the ABG-II
stem. The results obtained showed the same differences be-
tween stems.
Related to the evolution of BMD of the healthy hip, taken as a
control, a variation in bone mass of 3.2% to þ0.6% was observed.
The BMD varied from 300 to þ23.4 mgr/cm2 at the end of 12
months in the operated hip in contrast to the healthy hip, which
ranged from 30.4 to þ47.4 mgr/cm2. This difference was statisti-
cally significant only in area 7, in both groups. In the ABG-II group,
the average decrease of BMD in area 7 at the end of the study was
274 mg/cm2 in the operated hip, but dropping 21 mg/cm2 in the
control hip (P .001). In the ANATO group, the decrease of BMD in
area 7 was 148 mg/cm2 in the operated hip and 13 mg/cm2 in the
control hip (P .01).The clinical results were similar between implants, obtaining a
Merle D’Aubigne Postel (MDP) score of 7.5 (standard deviation [SD]:
1.27, min: 6, max: 12) preoperatively in the ABG-II group, which
reached 16.8 (SD: 1.20, min: 12 max: 18) at the end of the first
postoperative year. In the ANATO group, the preoperative clinical
MDP score was 7.7 (SD: 1.18, min: 6, max: 11) which reached, 1 year
postoperatively, 17.1 (SD: 1.21, min: 12, max: 18).
As for the radiological evolution, it was very frequent to find a
light bony atrophy at the shoulder of the stem and some rounding
at the level of the calcar in the ABG-II group at the end of the first
year, without any other changes in middle and distal areas. These
radiological changes coincided with the densitometric results.
However, in most of the patients in the ANATO group, there was
bone neoformation at the shoulder of the stems, and the remod-
eling changes at the calcar were less intense, all in accordance with
the densitometric results (Figs. 2 and 3).
Discussion
The implantation of a femoral stem modifies the model of
transmission of loads to the proximal femur, causing an adaptive
bone remodeling of multifactorial origin. Among these factors, it is
possible to distinguish those derived from the implant such as the
design, size, alloy, and extension of the porous coating. To deter-
mine the influence of the implant on the femoral remodeling, it is
necessary to minimize the variability in the surgical technique and
in the postoperative recovery in a group of patients who, clinically,
are very similar [15-17]. In addition, to accurately quantify those
changes in BMD, it has been proven that dual-energy radiograph
absorptiometry is a reliable method.
In densitometric studies with other implants, the variation of
the BMD of the proximal femur after the implantation of an
uncemented stem, at 3 and 6 months after the surgery, showed a
J.J. Panisello et al. / Arthroplasty Today 6 (2020) 480e486 485decrease from 4% to 50% in the preoperative bone mass, depending
on the implant and the surgical technique [18]. Among the main
reasons for these losses, we can mention the partial load during the
first weeks after the surgery and the immediate decrease of the
bone stock after the femoral preparation with rasps, which may
comprise up to 10% of the initial bone stock [19]. It is accepted that
most of the remodeling is stabilized at the end of the first post-
operative year, when the BMD reaches a plateau in all the areas
around the stem, reflecting the changes of the new hip biome-
chanics, according to Wolff's law [20].
Studies performed with the ABG-I® and ABG-II® models show
mild bone loss in zones 2 to 6 in both implants, already present at 3
and 6 months after implantation, with recovery at 12 months post-
operatively. In both stems, more pronounced losses were observed in
areas 1 and 7, but more intense in the ABG-I stem. The design of the
ABG-II stem, with a widening of the metaphyseal anteroposterior
diameter andwith a shorter and smaller tail than the ABG-I, improved
the pattern of load transmission to metaphyseal zones, explaining a
lower bone loss in proximal areas [12] that ranged from 7% to 16%. The
results of these anatomic models coincide with those observed in
other similar anatomic designs, which share the same proximal fixa-
tion philosophy. These implants seek a close match of the stem with
the proximal endosteal geometry, and stability is achieved through
metaphyseal fill and distal curve. As a result, they showed decreases of
9%-23% BMD in the proximal femur at the end of the first post-
operative year.With other designs, some variability has been observed
in the remodeling of the proximal femur at 12 months of evolution;
thus, single-wedge stems, with 3-point fixation along the stem length,
cause a decrease of 12%-38%. With tapered stems, drops of 26%-31%
have been documented. With rectangular, tapered stems, which
obtain 3-point fixation in the metaphyseal-diaphyseal junction and
proximal part of the diaphysis, the decrease was between 7% and 30%.
With custom-made stems, the proximal atrophy was between 7% and
24% [21,22]. With short stems, a 12.9% decrease in BMDwas observed
in the femoral calcar with the Metha stem (Aesculap Orthopaedics,
Germany), 18%-29% with the CFP stem (Waldemar Link, Germany),
and 6%-15% with the Nanos stem (Smith & Nephew, England). With
the Mayo stem (Zimmer Biomet, Warsaw, IN,), the proximal atrophy
reaches 14%-17%, andwith the Proxima (DePuy Synthes,Warsaw, IN, it
oscillates between 8% and 14% [23-25].
Analyzing the role that design differences between these im-
plants can cause in the remodeling, it can be suggested that, in
coincidence with other authors [26], the increased thickness and
porosity of the biological coating of the ANATO stem provides
stronger, more reliable osseointegration of superior quality and
quantity than the ABG-II stem. This improved fixation of the stem
favors the pattern of load transmission to be more similar to the
physiological load pattern of the nonoperated femur, minimizes the
atrophy at the proximal femur, and favors a positive remodeling.
Thus, greater bone preservation in the proximal femur could
theoretically reduce the risk of periprosthetic fractures and provide
an improved bone stock in case of implant revision.
This study has some limitations to consider. First, in both
groups, there are more men than women. Middle-aged men
usually have femurs with good bone quality, but this quality was
less frequent in the women received in our practice, so the indi-
cation for uncemented anatomic implants was lower in female
patients. Thus, the results obtained for the total group cannot be
extrapolated to the group of female patients. The same happens
with age. In both groups, the patients are relatively young, and this
pattern of remodeling in older patients cannot be guaranteed. The
follow-up of our study is relatively short, and we can expect
changes attributable to late remodeling in the longer term.
However, it is accepted that most of the adaptative changes of thefemur occur during the first postoperative year. Finally, the alloy of
the implants was different, but in both cases, the rigidity of the
implant exceeds 3 times the rigidity of the cortical bone (20 GPa)
and the small difference had no influence on the pattern of
remodeling [12].
In conclusion, both anatomic stems achieve an efficient trans-
mission of loads at the metaphyseal level that creates sufficient
stimulus for bone preservation. However, the greater porosity of
the biological coating of the ANATO stem obtains a better bone fit of
the implant at the proximal level. This favors bone preservation at
the proximal level, minimizing atrophy due to stress shielding.
Theoretically, this greater bone preservation can favor long-term
implant fixation and decrease the rate of revisions.Conflict of interest
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